Funding for this research was provided by:
Agence Nationale de la Recherche (ANR-12-RPIB-0010)
Received: 11 May 2020
Accepted: 26 August 2020
First Online: 10 September 2020
: FL. and O.T. have to disclose the patent WO2011/135101. O.T. has to disclose the patent WO2009/053644. These patents protect the AGuIX<sup>®</sup> NPs described in this publication. F.L. and O.T. are employees from NH TherAguix that is developing the AGuIX<sup>®</sup> NPs. FL, OT, LS and J-L. C. possess shares in NH TherAguix company. C.M. and S.C. are employees from Epithelix/OncoTheis that is developing and providing the epithelium cultures.